New Era of Weight Loss Medications: Basics & Beyond

Antipsychotic medications are known for their potential to induce weight gain. This side effect can have significant implications for individuals’ physical health, mental well-being, and treatment adherence.

The mechanisms behind this weight change can be complex and may involve alterations in metabolism, appetite regulation, or hormonal balance. Understanding the interplay between psychotropics and weight is crucial for both healthcare providers and individuals seeking mental health treatment, as it allows for informed decisions and proactive management of potential side effects.

In recent years, a groundbreaking shift has occurred in the realm of weight loss, ushering in a new era marked by the emergence of innovative medications. Despite the well-established benefits of a healthy diet and regular physical activity, many individuals struggle to achieve and maintain a sustainable weight. This has prompted a demand for novel approaches to weight loss that can address the diverse needs of individuals facing this health issue.

Let’s begin by answering this question first:

Q: When are injectable medications indicated for weight loss treatment?

Answer: BMI of 28 with sleep apnea

Injectable Medications are indicated for:

  • BMI >30 with no comorbid conditions
  • BMI >27 with comorbid medications including hypertension, diabetes, sleep apnea or hyperlipidemia.

This will be our academy’s new chapter addition in the Adverse Events: Antipsychotics section, where Dr. Satinderpal Kaur (Family Medicine) has summarized this clinically relevant topic:

NEW LECTURE ADDED FOR ACADEMY MEMBERS:

NEW ERA OF WEIGHT LOSS MEDICATIONS: BASICS & BEYOND

FOR ACADEMY MEMBERS
ACADEMY

JOIN EMAIL NEWSLETTER (FREE):

INTERESTED IN ACCESS TO THIS & OTHER CLINICALLY RELEVANT LECTURE SERIES?

JOIN ACADEMY MEMBERSHIP:

This is a closed membership for medical professionals only.

  • 400+ Clinically Relevant Chapters: Each chapter within these sections is of direct clinical relevance for your daily practice. 
  • Journal Club: we will post the most recently published psychiatry articles relevant to your daily clinical practice.
  • Clinical Case Discussion: Dr. Singh (Psychiatry) and Dr. Kaur (Family Medicine) discuss clinical cases to integrate the clinical cases from Psychiatry and Medicine.
  • Discussion Forum & Community: Connect with other medical professionals and discuss your difficult-to-treat clinical cases.
  • Goal: is to have all important clinically relevant topics in one place for ease of access.
GENERAL
$ 99/YR
  •  
STUDENTS
$ 75/YR
  •  

DISCOUNTS AVAILABLE FOR: Residents & Students ONLY.

Email us your student information (program information and way to confirm your student status) to: HSingh@PsychiatryEducationForum.com

© 2024 All Rights Reserved.

Related Articles